Equillium, Inc. (EQ)
USD 0.42
(2.41%)
USD 0.42
(2.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 35.95 Million USD | 129.9% |
| 2022 | 15.64 Million USD | 21823.61% |
| 2021 | -72 Thousand USD | -60.0% |
| 2020 | -45 Thousand USD | -95.65% |
| 2019 | -23 Thousand USD | -276.93% |
| 2018 | -6102.00 USD | -4901.64% |
| 2017 | -122.00 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 10.65 Million USD | 16.11% |
| 2024 Q2 | 13.81 Million USD | 29.66% |
| 2023 Q1 | 8.84 Million USD | -43.74% |
| 2023 Q4 | 9.17 Million USD | 3.84% |
| 2023 Q2 | 9.09 Million USD | 2.77% |
| 2023 FY | 35.95 Million USD | 129.9% |
| 2023 Q3 | 8.83 Million USD | -2.79% |
| 2022 Q3 | - USD | 100.0% |
| 2022 FY | 15.64 Million USD | 21823.61% |
| 2022 Q2 | -31 Thousand USD | -24.0% |
| 2022 Q1 | -25 Thousand USD | -31.58% |
| 2022 Q4 | 15.72 Million USD | 0.0% |
| 2021 FY | -72 Thousand USD | -60.0% |
| 2021 Q4 | -19 Thousand USD | 0.0% |
| 2021 Q1 | -17 Thousand USD | 0.0% |
| 2021 Q2 | -17 Thousand USD | 0.0% |
| 2021 Q3 | -19 Thousand USD | -11.76% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | -45 Thousand USD | -95.65% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | -23 Thousand USD | -276.93% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | -6102.00 USD | -4901.64% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | -122.00 USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 179.334% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 133.883% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -70.733% |
| Autolus Therapeutics plc | -4.86 Million USD | 838.812% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 995614.95% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 4406.347% |
| Shattuck Labs, Inc. | -2.38 Million USD | 1607.673% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 1593.893% |
| CervoMed Inc. | -1.29 Million USD | 2879.627% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 606.593% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 215.37% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 7677.364% |
| Precision BioSciences, Inc. | 40.47 Million USD | 11.153% |
| Dyadic International, Inc. | 922.95 Thousand USD | -3795.956% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 153.585% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 24561.224% |
| Nektar Therapeutics | 53.47 Million USD | 32.761% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 63.693% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -8380.66% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 13.116% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 8521.077% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 62.039% |
| GRI Bio, Inc. | 10.84 Million USD | -231.685% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -1315.677% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 513.929% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 37170.103% |
| Psyence Biomedical Ltd. | -240.00 USD | 14982600.0% |
| IGM Biosciences, Inc. | -211.66 Million USD | 116.989% |
| INmune Bio, Inc. | 155 Thousand USD | -23098.71% |
| Opthea Limited | 21.72 Thousand USD | -165452.486% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -8844.776% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 157.281% |
| Verastem, Inc. | -62 Thousand USD | 58096.774% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -1376.715% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 13877.011% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -1087.909% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 69.973% |
| NextCure, Inc. | -3.68 Million USD | 1076.059% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 369.19% |
| Organovo Holdings, Inc. | -5.38 Million USD | 767.248% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 71.8 Million USD | 49.919% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 3084.364% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -79.324% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 4474.453% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -492.738% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 76.77% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 136.611% |
| Senti Biosciences, Inc. | -2.68 Million USD | 1440.216% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -24562.551% |
| Apollomics, Inc. | 127 Thousand USD | -28213.386% |
| PureTech Health plc | -1.6 Million USD | 2343.169% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 224.13% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -4383.541% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 132.544% |
| Synaptogenix, Inc. | -6347.00 USD | 566635.371% |
| ChromaDex Corporation | 50.78 Million USD | 29.189% |
| Beam Therapeutics Inc. | -59.67 Million USD | 160.259% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 70.153% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 132.059% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 89.364% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 674.409% |
| Mesoblast Limited | -9.81 Million USD | 466.358% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 73.417% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 136.631% |
| MediWound Ltd. | 3.57 Million USD | -904.975% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -29865.0% |
| Fortress Biotech, Inc. | 57.85 Million USD | 37.846% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -83523.256% |
| Achilles Therapeutics plc | -4.73 Million USD | 860.008% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 71.376% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 182.732% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 156439.13% |
| Zai Lab Limited | 170.9 Million USD | 78.96% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -349.138% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -27560.0% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 79.781% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -126.807% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.514% |
| FibroGen, Inc. | 128.9 Million USD | 72.105% |
| Celcuity Inc. | -142.77 Thousand USD | 25285.611% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| ContextLogic Inc. | 59 Million USD | 39.054% |
| GH Research PLC | -315 Thousand USD | 11515.238% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -116.915% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -9143.702% |
| ImmuCell Corporation | 4.39 Million USD | -717.918% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 89.881% |
| Amarin Corporation plc | 165.54 Million USD | 78.278% |
| TG Therapeutics, Inc. | 219.1 Million USD | 83.589% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 6441.799% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 3345.307% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 147.605% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 51.013% |
| Aptorum Group Limited | -1.11 Million USD | 3325.835% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 90.757% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 88.995% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 53907.593% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 85.063% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 7058.544% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 1112.616% |
| Ardelyx, Inc. | 106.66 Million USD | 66.288% |
| Ainos, Inc. | -253.73 Thousand USD | 14271.59% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 177.377% |
| Prothena Corporation plc | -129.2 Million USD | 127.831% |
| HilleVax, Inc. | -2.15 Million USD | 1767.811% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 28.689% |
| Celularity Inc. | 6.75 Million USD | -432.317% |
| Rallybio Corporation | -150 Thousand USD | 24072.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 210.277% |
| Omeros Corporation | -69.77 Million USD | 151.531% |
| Humacyte, Inc. | -76.55 Million USD | 146.973% |
| Immunocore Holdings plc | 248.39 Million USD | 85.524% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 337.049% |
| Blueprint Medicines Corporation | 236.58 Million USD | 84.801% |
| IO Biotech, Inc. | -756 Thousand USD | 4856.349% |
| MEI Pharma, Inc. | 49.32 Million USD | 27.103% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 2621.599% |
| Summit Therapeutics Inc. | -2.05 Million USD | 1854.049% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 849.437% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -23.758% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 1364.346% |
| Pulmatrix, Inc. | -8.22 Million USD | 537.445% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 3173.333% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 1901.503% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 9112.03% |
| Acelyrin, Inc. | -115 Thousand USD | 31367.826% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 109.017% |
| Cytokinetics, Incorporated | -322.59 Million USD | 111.147% |
| Vor Biopharma Inc. | -3.49 Million USD | 1129.725% |
| Evogene Ltd. | 1.39 Million USD | -2470.264% |
| Replimune Group, Inc. | -2.65 Million USD | 1454.35% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 181.887% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 62825.465% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -424.398% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -3145.307% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 109063.636% |
| Atai Life Sciences N.V. | -5000.00 USD | 719260.0% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 37556.25% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -7149.597% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 2688.769% |
| Sagimet Biosciences Inc. | 2 Million USD | -1697.9% |
| MediciNova, Inc. | 979.7 Thousand USD | -3570.289% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 142.645% |
| MiMedx Group, Inc. | 266.84 Million USD | 86.525% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 38128.661% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 85.295% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 95.878% |
| Mereo BioPharma Group plc | 7.42 Million USD | -384.218% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 299750.0% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 719260.0% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 1561.113% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 685.54% |
| scPharmaceuticals Inc. | 9.78 Million USD | -267.594% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 152.116% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 92.444% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 315299.86% |
| Precigen, Inc. | 106 Thousand USD | -33822.642% |
| XOMA Corporation | 3.86 Million USD | -831.313% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 151.306% |
| Incyte Corporation | 3.44 Billion USD | 98.955% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 70967.166% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -143.058% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -188.587% |
| Seer, Inc. | 7.02 Million USD | -411.712% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 85.077% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 124093.103% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -276599900.0% |
| Akari Therapeutics, Plc | -4000.00 USD | 899050.0% |
| Novavax, Inc. | 639.93 Million USD | 94.381% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -18367.654% |
| UroGen Pharma Ltd. | 73.35 Million USD | 50.979% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 234.704% |
| Entera Bio Ltd. | -56 Thousand USD | 64310.714% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 19125.397% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -787.633% |
| Chimerix, Inc. | 324 Thousand USD | -10998.148% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 6949.143% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -6882.136% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 81475.034% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 98.942% |
| AnaptysBio, Inc. | 14.78 Million USD | -143.272% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -6140.769% |
| Portage Biotech Inc. | -54 Thousand USD | 66688.889% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 9637.931% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 2960.621% |
| OKYO Pharma Limited | -7506.16 USD | 479146.543% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 800055.506% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 1816160.606% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 16197397.297% |
| AbCellera Biologics Inc. | 38.02 Million USD | 5.436% |
| Genprex, Inc. | -15 Thousand USD | 239756.092% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 5482.934% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 315299.86% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 2.76 Million USD | -1198.347% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 2179.699% |
| Bicycle Therapeutics plc | -129.52 Million USD | 127.763% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 108.997% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 36.569% |
| Erasca, Inc. | -3.73 Million USD | 1063.505% |
| bluebird bio, Inc. | -4.03 Million USD | 992.258% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -3463.726% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 98.112% |
| DBV Technologies S.A. | 15.72 Million USD | -128.624% |
| Fortress Biotech, Inc. | 57.85 Million USD | 37.846% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 119.822% |
| CorMedix Inc. | -205.56 Thousand USD | 17592.533% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 73.123% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 6397.373% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -1296.97% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 191.396% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 132.357% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -47.061% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 1102.174% |
| Onconetix, Inc. | -1.12 Million USD | 3290.127% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -88.825% |
| Prime Medicine, Inc. | -147.9 Million USD | 124.312% |
| Adagene Inc. | 18.11 Million USD | -98.537% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -5804.433% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 25192.637% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 74.353% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 120.762% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 77.218% |
| SciSparc Ltd. | 2.19 Million USD | -1537.432% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 143650.641% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 116160.939% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 62.687% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 34.166% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 606.048% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 97.631% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 63.416% |
| ADMA Biologics, Inc. | 88.21 Million USD | 59.24% |
| Clene Inc. | 533 Thousand USD | -6646.341% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -49.146% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 3857.367% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -1708.753% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 18604.91% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 27.802% |
| Absci Corporation | -41.84 Million USD | 185.923% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.682% |
| Surrozen, Inc. | -27.23 Million USD | 232.053% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 146.339% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 176.769% |
| Cingulate Inc. | -582.91 Thousand USD | 6268.621% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 116093.548% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 475106.605% |
| Jaguar Health, Inc. | 7.72 Million USD | -365.536% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 4181.498% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 94.718% |
| Kronos Bio, Inc. | 1.37 Million USD | -2520.845% |
| Innoviva, Inc. | 261.06 Million USD | 86.226% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 167.003% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -23.444% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 345850.0% |
| Soligenix, Inc. | 97.31 Thousand USD | -36851.629% |
| AlloVir, Inc. | -398 Thousand USD | 9134.673% |
| Century Therapeutics, Inc. | -10.8 Million USD | 432.667% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 3584.302% |
| Kura Oncology, Inc. | -849 Thousand USD | 4335.336% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 21503.571% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 41.946% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 2487.188% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 5645.189% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 122932.548% |
| HCW Biologics Inc. | -574.82 Thousand USD | 6355.48% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 137.089% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 11588.179% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 61.933% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 20665.879% |
| Histogen Inc. | 3.76 Million USD | -854.046% |
| Surrozen, Inc. | -27.23 Million USD | 232.053% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 9714.439% |
| Kodiak Sciences Inc. | -25.94 Million USD | 238.582% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 273378.614% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 53663.927% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 1859.198% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -5518.438% |
| Moderna, Inc. | 2.15 Billion USD | 98.331% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 95.381% |
| Turnstone Biologics Corp. | 16.5 Million USD | -117.848% |
| Immix Biopharma, Inc. | -5468.00 USD | 657707.901% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 70605.882% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 77.716% |
| Exelixis, Inc. | 1.75 Billion USD | 97.954% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 677.917% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 65.458% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 97.384% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 3345.307% |
| Arcellx, Inc. | 108.27 Million USD | 66.791% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 30446.609% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -391.364% |
| Insmed Incorporated | 239.63 Million USD | 84.995% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 211.088% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 54.601% |
| Moolec Science SA | -143.3 Thousand USD | 25191.937% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 184.971% |
| Geron Corporation | -123.5 Million USD | 129.115% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -993.946% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -721.334% |
| Royalty Pharma plc | 1.79 Billion USD | 97.996% |
| OmniAb, Inc. | 14.66 Million USD | -145.163% |
| Alector, Inc. | -95.05 Million USD | 137.829% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 151.303% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 132.274% |
| Humacyte, Inc. | -76.55 Million USD | 146.973% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 3888.346% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 56.083% |
| 89bio, Inc. | -273 Thousand USD | 13271.429% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | -1.29 Million USD | 2876.68% |
| Immunic, Inc. | -111 Thousand USD | 32494.595% |
| Veracyte, Inc. | 248.14 Million USD | 85.509% |
| Genelux Corporation | -848 Thousand USD | 4340.33% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 29334.146% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 6375631.915% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 408.206% |
| Immunovant, Inc. | -231 Thousand USD | 15666.234% |
| Vericel Corporation | 135.57 Million USD | 73.478% |
| Fortrea Holdings Inc. | 424 Million USD | 91.519% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 141.731% |
| XBiotech Inc. | -1.74 Million USD | 2161.812% |
| Agenus Inc. | 139.61 Million USD | 74.245% |
| Acasti Pharma Inc. | -11 Thousand USD | 326990.909% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 992.915% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 17673.32% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 5645.189% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -113.998% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 172.427% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 417.542% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 9537.795% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 263.542% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 47.218% |
| United Therapeutics Corporation | 2.07 Billion USD | 98.263% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -665788.889% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 43641.649% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -54164.759% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1012.165% |
| Pharming Group N.V. | 220.1 Million USD | 83.663% |
| XOMA Corporation | 3.86 Million USD | -831.313% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 8376.691% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 3448.045% |
| Pyxis Oncology, Inc. | -2 Million USD | 1897.9% |
| uniQure N.V. | 2.21 Million USD | -1523.386% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 1992.526% |
| Cassava Sciences, Inc. | -89.42 Million USD | 140.211% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 16372.282% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 43951.22% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 139.055% |
| Pluri Inc. | 322 Thousand USD | -11067.081% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 287 Thousand USD | -12428.92% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 42.358% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 444.262% |
| CalciMedica, Inc. | -58 Thousand USD | 62096.552% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 216.501% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 90.068% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 357855.447% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 3448.045% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -1195.511% |
| Nutriband Inc. | 862.1 Thousand USD | -4070.954% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 10644.868% |
| Compugen Ltd. | 31.45 Million USD | -14.316% |
| Roivant Sciences Ltd. | 109.23 Million USD | 67.082% |
| ProKidney Corp. | -3.16 Million USD | 1234.68% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 127529.3% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -3069.278% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 145.707% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 29607.874% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -46.672% |
| Benitec Biopharma Inc. | 108 Thousand USD | -33194.444% |
| GeoVax Labs, Inc. | -20.72 Million USD | 273.536% |
| Biomea Fusion, Inc. | -4.2 Million USD | 955.939% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 11699.355% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 147.082% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 83.176% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 257.042% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 46200.0% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 3921.254% |
| Imunon, Inc. | -720 Thousand USD | 5094.132% |
| BioAtla, Inc. | -103.73 Million USD | 134.665% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 114.809% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 11662.058% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | -2.38 Million USD | 1605.779% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 6923.15% |
| Viridian Therapeutics, Inc. | -1 Million USD | 3667.262% |
| Galecto, Inc. | -830 Thousand USD | 4432.289% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 94.354% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -3113.405% |
| PolyPid Ltd. | -1.82 Million USD | 2073.546% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 30316.807% |
| Forte Biosciences, Inc. | -9000.00 USD | 399633.333% |
| Xencor, Inc. | -85.26 Million USD | 142.175% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 3691.361% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -18367.654% |
| Instil Bio, Inc. | -4.75 Million USD | 856.056% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 38128.661% |
| OncoCyte Corporation | 413 Thousand USD | -8606.538% |
| Elevation Oncology, Inc. | -39 Thousand USD | 92300.0% |
| Purple Biotech Ltd. | -196 Thousand USD | 18445.918% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -300.959% |
| MacroGenics, Inc. | 50.52 Million USD | 28.834% |
| Verona Pharma plc | -679.62 Thousand USD | 5390.867% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 20647.429% |
| Aditxt, Inc. | -111.66 Thousand USD | 32303.117% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | -44.26 Million USD | 181.239% |
| Curis, Inc. | 9.81 Million USD | -266.507% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 28915.271% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 15871.053% |
| BeiGene, Ltd. | 2.07 Billion USD | 98.27% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 127529.3% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 4029.836% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 852.732% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 6808.582% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 67.243% |
| Adicet Bio, Inc. | -6.09 Million USD | 689.669% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -7268.443% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | -73.91 Million USD | 148.65% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 8328.375% |
| Invivyd, Inc. | -2.02 Million USD | 1873.077% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 111.952% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 34862.853% |
| Moolec Science SA | -143.3 Thousand USD | 25191.937% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -356.842% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 719260.0% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 4401.196% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 56.893% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -49082.077% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 32.361% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 10286.402% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 282.537% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 3739.474% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 63920.951% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -66.897% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 88.536% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 12414.384% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 5515.361% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -796.038% |
| ImmunityBio, Inc. | -17.89 Million USD | 300.995% |
| Korro Bio, Inc. | -3.63 Million USD | 1090.579% |
| Kineta, Inc. | 5.43 Million USD | -561.844% |
| BioVie Inc. | -229.37 Thousand USD | 15776.376% |
| Codexis, Inc. | 57.33 Million USD | 37.283% |
| Celularity Inc. | 6.75 Million USD | -432.317% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -70977.288% |
| Cibus, Inc. | 1.42 Million USD | -2428.692% |
| Annexon, Inc. | -3.26 Million USD | 1200.643% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 186.154% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 79.21% |
| NeurAxis, Inc. | 2.15 Million USD | -1567.266% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 269.998% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 2002.54% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -15439.93% |
| Notable Labs, Ltd. | 113 Thousand USD | -31721.239% |
| IN8bio, Inc. | -2.5 Million USD | 1537.745% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 119960.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -1831.149% |
| Lumos Pharma, Inc. | 2 Million USD | -1691.629% |
| Liquidia Corporation | 14.6 Million USD | -146.288% |
| Mustang Bio, Inc. | -2.22 Million USD | 1716.09% |
| Quantum-Si incorporated | 488 Thousand USD | -7268.443% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 164.72% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 20647.429% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 279.467% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 34126.969% |
| Vaxcyte, Inc. | -75 Million USD | 147.944% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 121.466% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 3089.027% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -13.58% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 1936.466% |
| PepGen Inc. | -1.18 Million USD | 3136.993% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 28413.386% |
| Solid Biosciences Inc. | -76.56 Million USD | 146.965% |
| Palisade Bio, Inc. | 246 Thousand USD | -14517.073% |
| Nutriband Inc. | 862.1 Thousand USD | -4070.954% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 4805.695% |
| Belite Bio, Inc | -399 Thousand USD | 9112.03% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 178.945% |
| GeoVax Labs, Inc. | -20.72 Million USD | 273.536% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 109063.636% |
| Altimmune, Inc. | -65.37 Million USD | 155.004% |
| Peak Bio, Inc. | 367.76 Thousand USD | -9677.333% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 8328.375% |
| Neurogene Inc. | -3.26 Million USD | 1202.33% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 74.193% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 65478.182% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 1073.944% |
| Sesen Bio, Inc. | 40 Million USD | 10.105% |
| argenx SE | 1.1 Billion USD | 96.756% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 3089.027% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -1355.2% |
| Immunome, Inc. | -8.9 Million USD | 503.705% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 8912.587% |
| Design Therapeutics, Inc. | -537 Thousand USD | 6796.089% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -1575.582% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 12207.071% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 475.894% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -155.384% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 1445.971% |
| Athira Pharma, Inc. | -969 Thousand USD | 3810.836% |
| XOMA Corporation | 3.86 Million USD | -831.313% |
| Merus N.V. | -83.46 Million USD | 143.084% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 11267.081% |
| Rezolute, Inc. | -36 Thousand USD | 99983.333% |
| Clene Inc. | 533 Thousand USD | -6646.341% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 2800567.29% |
| BeyondSpring Inc. | 1.75 Million USD | -1953.569% |
| Synlogic, Inc. | -1.92 Million USD | 1968.919% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 97283.784% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 667.877% |
| Peak Bio, Inc. | 367.76 Thousand USD | -9677.333% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 289.622% |
| Krystal Biotech, Inc. | 47.6 Million USD | 24.466% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 74.514% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -615.582% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 1488.759% |
| MannKind Corporation | 136.19 Million USD | 73.597% |
| Ikena Oncology, Inc. | -50.49 Million USD | 171.215% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 66.955% |
| Gossamer Bio, Inc. | -4.38 Million USD | 920.023% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 14369.048% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 719260.0% |
| Legend Biotech Corporation | 140.92 Million USD | 74.485% |
| Mural Oncology plc | -2.56 Million USD | 1500.779% |
| Disc Medicine, Inc. | -100 Thousand USD | 36058.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -73.258% |
| REGENXBIO Inc. | 53.02 Million USD | 32.192% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 771.24% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 18791.618% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 2176.097% |
| Vaxart, Inc. | -60.76 Million USD | 159.177% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 13783.69% |
| Cellectis S.A. | 18 Thousand USD | -199666.667% |
| Longeveron Inc. | 221 Thousand USD | -16170.588% |
| Repare Therapeutics Inc. | -80.07 Million USD | 144.908% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 96.71% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 2878.825% |
| Revolution Medicines, Inc. | -399.66 Million USD | 108.997% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 102837.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -73283.673% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.582% |
| Denali Therapeutics Inc. | -93.34 Million USD | 138.522% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 143650.641% |
| Veru Inc. | 7.56 Million USD | -375.262% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 23913.245% |
| Cingulate Inc. | -582.91 Thousand USD | 6268.621% |
| Passage Bio, Inc. | -3.72 Million USD | 1066.353% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 298655.297% |
| Exicure, Inc. | -1.42 Million USD | 2626.915% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 9488.512% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -1230.3% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 7113.8% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 24134.972% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 160.734% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -9096.419% |
| OmniAb, Inc. | 14.66 Million USD | -145.163% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -79.853% |
| Lipocine Inc. | -2.85 Million USD | 1361.322% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 2051.058% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 730.289% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 2487.188% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 52.257% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 55420.0% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 57.343% |
| Ocugen, Inc. | -33.53 Million USD | 207.219% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 1237.192% |
| Q32 Bio Inc. | 578 Thousand USD | -6121.107% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 13669.057% |
| Alumis Inc. Common Stock | -1.28 Million USD | 2900.467% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 2206.503% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -7081.847% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 869911.321% |
| Dominari Holdings Inc. | 2.03 Million USD | -1663.512% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 19698.738% |
| vTv Therapeutics Inc. | -13.59 Million USD | 364.494% |
| Bio-Techne Corporation | 773.07 Million USD | 95.349% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -107.622% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 92.196% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 3175.962% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 249.95% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -207.412% |
| Nkarta, Inc. | -5.86 Million USD | 712.677% |
| BioCardia, Inc. | -7.24 Million USD | 596.041% |
| Iterum Therapeutics plc | -1.75 Million USD | 2154.743% |